Basell Now Licensing Metocene PP Technology

Basell has announced the company will start licensing on a worldwide basis its Metocene PP technology, which is used in the production of polyolefins based on single-site catalyst systems.

“Metocene PP technology can be adapted to virtually any polypropylene process,” said Kaspar Evertz, Basell’s senior vice president of Licensing. “It is a highly versatile technology that extends the product range of conventional PP.”

Metocene PP license packages are customized to address the needs of individual licensees and can include intellectual property rights, process upgrades, technical and product information as well as customized single-site catalyst systems.

Evertz added, “Product advantages that Basell customers are seeing with Metocene PP technology include lower levels of extractables and xylene solubles, improved transparency and peroxide-free reactor grades. Higher processing speeds at reduced melt viscosities can also be achieved.”

In addition to Metocene PP technology, Basell also licenses a comprehensive portfolio of polypropylene and polyethylene processes:

  • Spheripol – polypropylene technology for the production of homopolymer, random and heterophasic copolymers.
  • Spherizone – latest generation polypropylene technology based on new multi-zone reactor technology.
  • Spherilene – swing gas phase process for the production of LLDPE, MDPE and HDPE.
  • Hostalen - low-pressure slurry process for the production of bi-modal HDPE.
  • Lupotech T – high pressure tubular reactor process for the production of LDPE and EVA copolymers.

http://www.basell.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.